Navigation Links
Wonder drug Dasatinib gives hopes to leukemia patients

The company Bristol-Myers Squibb Co at Boston told the press that the drug Dasatinib has led to reduction in the number of patients with Chronic myeloid leukemia (CML).//

This drug is very effective in the decreasing the leukemia cells from the bone marrow than the previously used drug Gleevec.

Chronic myeloid leukemia (CML) is usually presented in three different stages – Chronic stage, accelerated stage and the blast stage. Dasatinib was tried on all these stages of leukemia patients and the results were Out of the186 patients who are in the chronic stage, 45% of the patients attained complete elimination of the leukemia cells from the marrow.

Out of the 107 patients in the accelerated stage 31% who did not react to Gleevec responded positively to Dasatinib.

Out of the 74% in the blast stage (aggressive form) 29% of the patients attained complete elimination of the leukemia cells.

This is a boon to all those patients who do not react to Gleevec which is the treatment for Leukemia.

This drug will soon reach the markets by the end of the current year or the beginning of the next year.

Gleevec was a Swiss product and in 2001after approved by the Food and Drug Administration, made to the markets as the drug which attacks the BCR-ABL protein which results in the abnormal rise of leukocytes.

But with this drug some patients (20% of CML) did not respond to the drug or initially responded but later became resistant to the drug.

The mechanism of the drug action is that it attacks and prevents several proteins (BCR-ABL & SRC) in the same time. SRC is believed to help the leukemia cells to take the alternate pathway and become resistant to Gleevec, but Dasatinib prevents the action of SRC.

The toxicity level of Dasatinib is not more than Gleevec and it has to be brought in to the market for commercial use as the statistics show that in the current year the number of ch ronic CML patients to be 4600.

The company also relies on this drug to become the most famous cancer Drug Company and increase profit. It is estimated that this drug if put in circulation would yield six hundred million dollars to the company within a period of four years.
'"/>




Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Wonder drug - could end in disaster
3. Have You Ever Wondered How We Perceive Different Sounds?
4. Soy Not Such A Wonder For Health?
5. Have You Ever Wondered Why Male And Female Voices Differ?
6. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
7. Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.
8. Braces Work Wonders In Setting Crooked Teeth Right
9. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
10. Save Budhia - The Indian Wonder Kid
11. Wonder Drug For Weight Loss Launched In UK
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
Breaking Medicine Technology: